Calciphylaxis and Kidney Disease: A Review.
Gallo Marin B, Aghagoli G, Hu SL, Massoud CM, Robinson-Bostom L.
Am J Kidney Dis. 2023 Feb;81(2):232-239. doi: 10.1053/j.ajkd.2022.06.011. Epub 2022 Aug 12.
Calciphylaxis.
Nigwekar SU, Thadhani R, Brandenburg VM.
N Engl J Med. 2018 May 3;378(18):1704-1714. doi: 10.1056/NEJMra1505292.
Calciphylaxis: Part I. Diagnosis and pathology.
Rick J, Strowd L, Pasieka HB, Saardi K, Micheletti R, Zhao M, Kroshinsky D, Shinohara MM, Ortega-Loayza AG.
J Am Acad Dermatol. 2022 May;86(5):973-982. doi: 10.1016/j.jaad.2021.10.064. Epub 2022 Feb 1.
Calciphylaxis.
Nigwekar SU.
Curr Opin Nephrol Hypertens. 2017 Jul;26(4):276-281. doi: 10.1097/MNH.0000000000000328.
Calciphylaxis: Treatment and outlook-CME part II.
Rick J, Rrapi R, Chand S, Shinohara MM, Strowd L, Pasieka HB, Micheletti R, Kroshinsky D, Ortega-Loayza AG.
J Am Acad Dermatol. 2022 May;86(5):985-992. doi: 10.1016/j.jaad.2021.10.063. Epub 2022 Feb 22.
Calciphylaxis: Diagnosis, Pathogenesis, and Treatment.
Chang JJ.
Adv Skin Wound Care. 2019 May;32(5):205-215. doi: 10.1097/01.ASW.0000554443.14002.13.
Calciphylaxis and its co-occurrence with connective tissue diseases.
Zhou Y, Chen Y, Yin G, Xie Q.
Int Wound J. 2023 Apr;20(4):1316-1327. doi: 10.1111/iwj.13972. Epub 2022 Oct 23.
Calciphylaxis-as a drug induced adverse event.
Portales-Castillo I, Kroshinsky D, Malhotra CK, Culber-Costley R, Cozzolino MG, Karparis S, Halasz CL, Goverman J, Manley HJ, Malhotra R, Nigwekar SU.
Expert Opin Drug Saf. 2019 Jan;18(1):29-35. doi: 10.1080/14740338.2019.1559813. Epub 2018 Dec 24.
Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Wen W, Portales-Castillo I, Seethapathy R, Durant O, Mengesha B, Krinsky S, Kroshinsky D, Kalim S, Goverman J, Nazarian RM, Chitalia V, Malhotra R, Kramann R, Malhotra CK, Nigwekar SU.
JAMA Netw Open. 2023 Apr 3;6(4):e2310068. doi: 10.1001/jamanetworkopen.2023.10068.
Calciphylaxis.
Ng AT, Peng DH.
Dermatol Ther. 2011 Mar-Apr;24(2):256-62. doi: 10.1111/j.1529-8019.2011.01401.x.
